First, C-peptide reflects the endogenous insulin secretion of diabetes patients [31, 32] and is related to the improvement of blood glucose control and the reduction of blood glucose variability [24, 33–36], which is conducive to reducing DR risk. This evidence concerns the gene INS and diabetes mellitus.